Legal & General Group PLC Vaxcyte, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 109,090 shares of PCVX stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,090

Previous 109,090 -0.0%

Holding current value

$10.3 Million

Previous $12.5 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $289,555 - $480,894	4,106 Added 3.91%	109,090 $12.5 Million
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $612,672 - $803,532	10,201 Added 10.76%	104,984 $7.93 Million
Q1 2024 May 14, 2024	BUY	$59.79 - $81.05 $883,696 - $1.2 Million	14,780 Added 18.47%	94,783 $6.47 Million
Q4 2023 Feb 15, 2024	BUY	$45.35 - $63.41 $207,385 - $289,973	4,573 Added 6.06%	80,003 $5.02 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $223,146 - $257,588	4,851 Added 6.87%	75,430 $3.85 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $154,479 - $240,989	4,457 Added 6.74%	70,579 $3.52 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $1.44 Million - $1.88 Million	39,805 Added 151.25%	66,122 $2.48 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $217,592 - $506,975	10,573 Added 67.16%	26,317 $1.26 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $6,702 - $8,815	309 Added 2.0%	15,744 $378,000
Q2 2022 Aug 22, 2022	BUY	$17.68 - $26.58 $116,528 - $175,188	6,591 Added 74.53%	15,435 $337,000
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $12,693 - $19,163	727 Added 8.96%	8,844 $214,000
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $2,685 - $3,676	-139 Reduced 1.68%	8,117 $194,000
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $83,552 - $111,224	4,124 Added 99.81%	8,256 $210,000
Q2 2021 Aug 12, 2021	BUY	$16.45 - $24.06 $8,044 - $11,765	489 Added 13.42%	4,132 $93,000
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $17,652 - $27,585	946 Added 35.08%	3,643 $72,000
Q4 2020 Feb 12, 2021	BUY	$26.57 - $51.74 $16,632 - $32,389	626 Added 30.23%	2,697 $71,000
Q3 2020 Nov 13, 2020	BUY	$26.5 - $55.4 $54,881 - $114,733	2,071 New	2,071 $102,000

Others Institutions Holding PCVX

# of Institutions

354

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.57B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Vaxcyte, Inc. Transaction History